rosmarinic-acid and Carbon-Tetrachloride-Poisoning

rosmarinic-acid has been researched along with Carbon-Tetrachloride-Poisoning* in 2 studies

Other Studies

2 other study(ies) available for rosmarinic-acid and Carbon-Tetrachloride-Poisoning

ArticleYear
Rosmarinic acid ameliorates acute liver damage and fibrogenesis in carbon tetrachloride-intoxicated mice.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2013, Volume: 51

    The aim of this study was to investigate the therapeutic potential of rosmarinic acid (RA), a natural phenolic, in the treatment of acute liver toxicity. RA at 10, 25 and 50mg/kg was administered by gavage once daily for 2 consecutive days, 6h after CCl(4) intoxication. CCl(4) intoxication caused hepatic necrosis and increased serum ALT activity. In the livers, oxidative/nitrosative stress was evidenced by increased 3-nitrotyrosine (3-NT) and thiobarbituric acid reactive substances (TBARS) formation and a significant decrease in Cu/Zn superoxide dismutase (SOD) activity. CCl(4) administration triggered inflammatory response in mice livers by activating nuclear factor-kappaB (NF-κB), which coincided with the induction of tumor necrosis factor-alpha (TNF-α) and cyclooxygenase-2 (COX-2). RA improved histological and serum markers of liver damage and significantly ameliorated oxidative/nitrosative stress and inflammatory response in liver tissue. Additionally, RA prevented transforming growth factor-beta1 (TGF-β1) and alpha-smooth muscle actin (α-SMA) expression, suggesting suppression of profibrotic response. Furthermore, RA significantly inhibited the CCl(4)-induced apoptosis, which was evident from decreased cleavage of caspase-3. The hepatoprotective activity of RA coincided with enhanced NF-E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) expression. The results of this study indicates that RA possesses antioxidant, anti-inflammatory, antiapoptotic and antifibrotic activity against acute liver toxicity.

    Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cinnamates; Cyclooxygenase 2; Depsides; Dose-Response Relationship, Drug; Liver; Liver Failure, Acute; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Rosmarinic Acid; Superoxide Dismutase; Transforming Growth Factor beta1

2013
In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:3-4

    This study was carried out to investigate whether rosmarinic acid (RA) has antifibrotic effect on experimental liver fibrosis in vitro and in vivo and its possible mechanism. Culture of hepatic stellate cells (HSCs) determine proliferation and expression of transforming growth factor-beta1 (TGF-beta1), connective transforming growth factor (CTGF) and alpha-smooth muscle actin (alpha-SMA). In carbon tetrachloride (CCL(4))-induced rat liver fibrosis model, determined biochemical indicator, liver fibrosis grade and histopathological changes, immunohistochemical detected liver TGF-beta1 and CTGF expression. The results indicated that RA could inhibit HSCs proliferation, inhibit TGF-beta1, CTGF and alpha-SMA expression in cultured HSCs. It has marked evident in reducing fibrosis grade, ameliorating biochemical indicator and histopathological morphology, reducing liver TGF-beta1 and CTGF expression in CCL(4)-induced liver fibrosis. These findings suggest that RA has potentially conferring antifibrogenic effects.

    Topics: Actins; Animals; Antioxidants; Carbon Tetrachloride Poisoning; Cell Proliferation; Cells, Cultured; Cinnamates; Connective Tissue Growth Factor; Depsides; Disease Models, Animal; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Rosmarinic Acid; Transforming Growth Factor beta1

2010